The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avelumab plus axitinib in advanced renal cell carcinoma (aRCC): 12-month interim results from a real-world observational study in the United Kingdom.
 
Paul D. Nathan
Consulting or Advisory Role - 4SC; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Immunocore; Ipsen; Merck; MSD; Novartis; Pfizer; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; Merck; MSD; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Iqtedar Ahmed Muazzam
Speakers' Bureau - Ipsen
Travel, Accommodations, Expenses - Ipsen
 
Ricky Frazer
Honoraria - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; MSD; Novartis
 
Anand Sharma
No Relationships to Disclose
 
Joseph David Hickey
Employment - OPEN Health
Consulting or Advisory Role - OPEN Health
Research Funding - OPEN Health
 
Aimi Rose Ritchie
Employment - Pfizer; Pfizer (I)
Leadership - Emblation (I)
Stock and Other Ownership Interests - Pfizer